QoL scores across diagnosis
Post-transplant QoL scores also were compared between patients with
malignant and non-malignant conditions (Supplemental Table S1). Patients
receiving HSCT for non-malignant conditions had a significantly higher
physical functioning score (80.47) compared to those with malignant
conditions (70.34; p = 0.04). Similarly, on average patients with
non-malignant conditions had a higher work/school functioning score
(74.93) compared to those with malignant conditions (64.30; p =
0.02).